NCT04968756View on ClinicalTrials.gov

Evaluating the Safety of the SPECTRALIS CENTAURUS Device

NARecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 9, 2021

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Retinal Diseases
Interventions
DEVICE

Selective retina therapy SPECTRALIS CENTAURUS device

Microsecond laser microsurgery by using the SPECTRALIS CENTAURUS device

Trial Locations (1)

3010

RECRUITING

University Hospital Inselspital, Bern

All Listed Sponsors
collaborator

Bern University of Applied Sciences

OTHER

lead

Insel Gruppe AG, University Hospital Bern

OTHER